| G-CSF in Decompensated Cirrhosis: an Open Label Trial (NCT03415698) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer (NCT02849314) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Low dosE GlibENclamide in Diabetes Part A (NCT02830048) | University of Oxford | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver (NCT02849015) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer (NCT02849379) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy (NCT02637700) | Academisch Ziekenhuis Maastricht | 2016-07-01 |
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer (NCT02797964) | Sierra Oncology LLC - a GSK company | 2016-07-01 |
| Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury (NCT02669849) | Vertex Pharmaceuticals Incorporated | 2016-07-01 |
| A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) (NCT02612558) | Rigel Pharmaceuticals | 2016-07-01 |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor (NCT02839954) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-07-01 |
| Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure (NCT01587222) | Anna Cruceta | 2016-07-01 |
| Periodontally Accelerated Osteogenic Orthodontics With BMP2 (NCT03396900) | SVS Institute of Dental Sciences | 2016-07-01 |
| Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy (NCT02611336) | Andrea M. Isidori | 2016-07-01 |
| Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis (NCT03146481) | Cairo University | 2016-07-01 |
| A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT02810951) | Castle Creek Biosciences, LLC. | 2016-07-01 |
| Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease (NCT02824913) | Parion Sciences | 2016-07-01 |
| Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis (NCT03163420) | Cairo University | 2016-07-01 |
| Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC (NCT02835924) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2016-07-01 |
| Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma (NCT02848794) | The First People's Hospital of Lianyungang | 2016-07-01 |
| Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder (NCT02803229) | New York State Psychiatric Institute | 2016-07-01 |
| An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis (NCT02762500) | Lycera Corp. | 2016-07-01 |
| Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury (NCT02849223) | Minneapolis Veterans Affairs Medical Center | 2016-07-01 |
| Phase II Study of BNC210 in PTSD (NCT02933606) | Bionomics Limited | 2016-06-30 |
| Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer (NCT03907098) | Zhejiang Cancer Hospital | 2016-06-30 |
| Does CERC-501 Attenuate Stress-precipitated Smoking Lapse? (NCT02800928) | Yale University | 2016-06-30 |
| Fish Oil Brain Delivery Study (NCT02541929) | University of Southern California | 2016-06-30 |
| Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb) (NCT02796651) | AstraZeneca | 2016-06-30 |
| Candesartan's Effects on Alzheimer's Disease And Related Biomarkers (NCT02646982) | Emory University | 2016-06-30 |
| A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease (NCT02662582) | Astellas Pharma Global Development, Inc. | 2016-06-30 |
| MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma (NCT02724020) | Millennium Pharmaceuticals, Inc. | 2016-06-30 |
| Prospective Study Assessing Thyroidectomy Using Robot (NCT02839655) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-06-30 |
| Effect of MD1003 in Amyotrophic Lateral Sclerosis (NCT03114215) | MedDay Pharmaceuticals SA | 2016-06-29 |
| Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers (NCT02803203) | Memorial Sloan Kettering Cancer Center | 2016-06-29 |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies (NCT02807844) | Novartis Pharmaceuticals | 2016-06-29 |
| Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma (NCT02743819) | University of Chicago | 2016-06-28 |
| Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (NCT02656017) | Kyongtae Ty Bae, M.D., Ph.D. | 2016-06-27 |
| Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal (NCT02788786) | Johns Hopkins Bloomberg School of Public Health | 2016-06-27 |
| Plasmodium Immunotherapy for Lung Cancer (NCT02786589) | State Key Laboratory of Respiratory Disease | 2016-06-27 |
| Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies (NCT02629692) | Sun Pharma Advanced Research Company Limited | 2016-06-27 |
| Open Trail of γIFN for Friedreich Ataxia (NCT03888664) | IRCCS Eugenio Medea | 2016-06-26 |
| Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness (NCT03270787) | Tasly Pharmaceuticals, Inc. | 2016-06-24 |
| Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan (NCT02747537) | Washington University School of Medicine | 2016-06-24 |
| Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery (NCT02730546) | Mayo Clinic | 2016-06-24 |
| Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer (NCT02735239) | Ludwig Institute for Cancer Research | 2016-06-24 |
| 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis (NCT02667457) | Advanced Accelerator Applications | 2016-06-23 |
| Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib (NCT02398825) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2016-06-23 |
| Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism (NCT02923115) | Daiichi Sankyo | 2016-06-23 |
| 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement (NCT02756650) | Novartis Pharmaceuticals | 2016-06-23 |
| Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant (NCT02797470) | AIDS Malignancy Consortium | 2016-06-23 |
| A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection (NCT02792582) | St. Jude Children's Research Hospital | 2016-06-22 |
| Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant (NCT02684162) | M.D. Anderson Cancer Center | 2016-06-22 |
| Atrovent in Exercise Induced Laryngeal Obstruction (EILO) (NCT02755714) | Haukeland University Hospital | 2016-06-22 |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (NCT02589145) | M.D. Anderson Cancer Center | 2016-06-22 |
| Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response (NCT02852486) | University of Campinas, Brazil | 2016-06-22 |
| A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma (NCT02718833) | Massachusetts General Hospital | 2016-06-21 |
| Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy (NCT02731729) | Parker Institute for Cancer Immunotherapy | 2016-06-21 |
| Oral Nutritional Supplementation in Picky Eating Children (NCT02523027) | Abbott Nutrition | 2016-06-21 |
| A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors (NCT02819843) | Memorial Sloan Kettering Cancer Center | 2016-06-21 |
| An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab (NCT02754141) | Bristol-Myers Squibb | 2016-06-21 |
| Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy (NCT02661854) | Inmunotek S.L. | 2016-06-21 |
| Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer (NCT02516670) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-20 |
| Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T) (NCT06357988) | National Cancer Institute (NCI) | 2016-06-20 |
| A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors (NCT02697591) | Incyte Biosciences International Sàrl | 2016-06-20 |
| Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (NCT02781506) | University of Texas Southwestern Medical Center | 2016-06-20 |
| Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT02744612) | City of Hope Medical Center | 2016-06-20 |
| SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC (NCT03578874) | The University of Hong Kong | 2016-06-20 |
| Anti-Inflammatory Agent in Sinusitis (NCT02874144) | Northwestern University | 2016-06-20 |
| Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis (NCT03835507) | Hanyang University Seoul Hospital | 2016-06-20 |
| A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) (NCT02588651) | Deepa Jagadeesh | 2016-06-17 |
| Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02581943) | Wake Forest University Health Sciences | 2016-06-17 |
| An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread (NCT02737475) | Bristol-Myers Squibb | 2016-06-17 |
| A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NCT02791191) | Eli Lilly and Company | 2016-06-16 |
| Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) (NCT02572843) | Swiss Cancer Institute | 2016-06-16 |
| Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders (NCT02757066) | Nobelpharma | 2016-06-16 |
| A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) (NCT02632721) | Boehringer Ingelheim | 2016-06-16 |
| A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer (NCT02716116) | Takeda | 2016-06-16 |
| Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis (NCT02799472) | GlaxoSmithKline | 2016-06-15 |
| COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC (NCT02484664) | Brigham and Women's Hospital | 2016-06-15 |
| Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face (NCT02723721) | Centre Hospitalier Universitaire de Nice | 2016-06-15 |
| Addressing Post Cessation Weight Gain (NCT02412631) | Mayo Clinic | 2016-06-15 |
| A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II (NCT02707055) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2016-06-15 |
| Oxytocin and Social Cognitive Skills Groups (NCT02918864) | Rush University Medical Center | 2016-06-15 |
| Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC (NCT02795429) | Novartis Pharmaceuticals | 2016-06-15 |
| Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT02715609) | Washington University School of Medicine | 2016-06-15 |
| A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) (NCT02720510) | Novartis Pharmaceuticals | 2016-06-14 |
| Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. (NCT02732119) | Novartis Pharmaceuticals | 2016-06-14 |
| Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer (NCT02636582) | National Cancer Institute (NCI) | 2016-06-14 |
| Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID) (NCT02737384) | Assistance Publique - Hôpitaux de Paris | 2016-06-14 |
| P.Vivax Treatment Trial (NCT02802813) | University of Oxford | 2016-06-14 |
| CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer (NCT02067741) | Swiss Cancer Institute | 2016-06-14 |
| A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors (NCT02795858) | Dana-Farber Cancer Institute | 2016-06-14 |
| Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer (NCT02383433) | Case Comprehensive Cancer Center | 2016-06-14 |
| Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C (NCT02612129) | ZevraDenmark | 2016-06-14 |
| A Randomized Comparison of Pediatric I-gel, Air-Q With Classic Laryngeal Mask Airway (NCT02757820) | Assiut University | 2016-06-14 |
| Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults (NCT02669121) | Takeda | 2016-06-14 |
| Shave Margins in Breast Conservation Therapy (NCT02462200) | Washington University School of Medicine | 2016-06-13 |
| A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma (NCT02776891) | University of California, San Francisco | 2016-06-13 |
| Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants (NCT02792192) | Hoffmann-La Roche | 2016-06-13 |
| Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) (NCT02781584) | Gilead Sciences | 2016-06-13 |
| Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis (NCT02424396) | Assistance Publique - Hôpitaux de Paris | 2016-06-13 |